| Literature DB >> 32579715 |
Fatima Abdelfattah1, Ariana Kariminejad2, Anne-Karin Kahlert3,4, Patrick J Morrison5, Evren Gumus6, Katherine D Mathews7, Benjamin W Darbro7, David J Amor8,9,10, Maie Walsh8, Yves Sznajer11, Luisa Weiß3, Sabine Weidensee12, David Chitayat13,14, Patrick Shannon15, Eva Bermejo-Sánchez16, Isolina Riaño-Galán17,18,19, Ian Hayes20, Gemma Poke21, Caroline Rooryck22, Perrine Pennamen22, Suonavy Khung-Savatovsky23, Annick Toutain24, Marie-Laure Vuillaume24, Siavash Ghaderi-Sohi2, Mohamad H Kariminejad2, Sönke Weinert25, Heinrich Sticht26, Martin Zenker1, Denny Schanze1.
Abstract
Serine biosynthesis disorders comprise a spectrum of very rare autosomal recessive inborn errors of metabolism with wide phenotypic variability. Neu-Laxova syndrome represents the most severe expression and is characterized by multiple congenital anomalies and pre- or perinatal lethality. Here, we present the mutation spectrum and a detailed phenotypic analysis in 15 unrelated families with severe types of serine biosynthesis disorders. We identified likely disease-causing variants in the PHGDH and PSAT1 genes, several of which have not been reported previously. Phenotype analysis and a comprehensive review of the literature corroborates the evidence that serine biosynthesis disorders represent a continuum with varying degrees of phenotypic expression and suggest that even gradual differences at the severe end of the spectrum may be correlated with particular genotypes. We postulate that the individual residual enzyme activity of mutant proteins is the major determinant of the phenotypic variability, but further functional studies are needed to explore effects at the enzyme protein level.Entities:
Keywords: Neu-Laxova syndrome; PHGDH; PSAT1; autosomal recessive; genotype-phenotype correlation; l-serine biosynthesis
Year: 2020 PMID: 32579715 DOI: 10.1002/humu.24067
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878